Primary information |
---|
PRRID | PRRID_0434 |
Ligand Name | Cinnamaldehyde |
Source | China Medicine (Group) Shanghai Chemical Reagent(others) |
Sequence of ligand | C1=CC=C(C=C1)C=CC=O |
Length | NA |
Type | Drug |
Occurence | Synthetic |
Role of Ligand | It inhibits the NF- |
Name of receptor | Toll-like receptor 4 (TLR4) |
Type of receptor | Toll-like receptor (TLR) |
Source | coxsackievirus B3 (CVB3)-induced viral myocarditis (VMC) |
Localization | Heart |
Domain | Leucine-rich Repeat (LRR) Domain |
Sequence of Receptor | NA |
Swiss prot ID | NA |
Length Of Receptor | NA |
Function | It has antiviral effects on VMC through its metabolite, cinnamic acid. |
Assay used | NA |
PMID | 20460981 |
Year of Publication | 2010 |
Pubchem assay | NA |
Primary information |
---|
PRRID | PRRID_0434 |
Ligand Name | Cinnamaldehyde |
Source | China Medicine (Group) Shanghai Chemical Reagent(others) |
Sequence of ligand | C1=CC=C(C=C1)C=CC=O |
Length | NA |
Type | Drug |
Occurence | Synthetic |
Role of Ligand | It inhibits the NF- |
Name of receptor | Toll-like receptor 4 (TLR4) |
Type of receptor | Toll-like receptor (TLR) |
Source | coxsackievirus B3 (CVB3)-induced viral myocarditis (VMC) |
Localization | Heart |
Domain | Leucine-rich Repeat (LRR) Domain |
Sequence of Receptor | NA |
Swiss prot ID | NA |
Length Of Receptor | NA |
Function | It has antiviral effects on VMC through its metabolite, cinnamic acid. |
Assay used | NA |
PMID | 20460981 |
Year of Publication | 2010 |
Pubchem assay | NA |